Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of a lncRNA for treatment of melanoma

Inhibition of a lncRNA for treatment of melanoma

US Patent RE48801 · Granted Nov 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Direct and selective inhibition of MDM4 for treatment of cancer2024
Usages of recombinant extracellular vesicles2024
Usages of recombinant extracellular vesicles2024
Inhibition of a lncRNA for treatment of neuroblastoma2022
Inhibition of NEAT1 for treatment of solid tumors2021
Reduced size self-delivering nucleic acid compounds targeting long non-coding RN2021
Direct and selective inhibition of MDM4 for treatment of cancer2020
Inhibition of a lncRNA for treatment of melanoma2017
Inhibition of a lncRNA for treatment of melanoma2017
Inhibition of a lncRNA for treatment of melanoma2017
Inhibition of a lncRNA for treatment of melanoma2017
Inhibition of NEAT1 for treatment of solid tumors2017